Malik Hazley
Family Medicine · Murfreesboro, TNNPI 1235620212
Payments from drug & device makers
Across 55 payments — averaging $19.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$158
- Novo Nordisk$117
- Merck$98
- Boehringer Ingelheim$86
- Pfizer$72
- Novartis$58
- plus $494 from 18 others
What the payments were for
- Food & beverage$1,082100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 7 | $158 |
| Novo Nordisk | 7 | $117 |
| Merck | 6 | $98 |
| Boehringer Ingelheim | 4 | $86 |
| Pfizer | 4 | $72 |
| Novartis | 3 | $58 |
| AbbVie | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $48 |
| Exact Sciences | 2 | $33 |
| Qorumpartners | 1 | $32 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $28 |
| Innovation Technologies Inc | 1 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Johnson & Johnson | 1 | $23 |
| Gilead | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $22 |
| Sunovion Pharmaceuticals Inc. | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Kerecis Limited | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Amgen | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Endogastric Solutions, Inc | 1 | $14 |
How this compares
$1,082 in reported general payments places this provider in the 60th percentile of 2,087 family medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 42 | $46,761 |
| EliquisApixaban | 23 | $21,075 |
| Advair HfaFluticasone Propion/Salmeterol | 17 | $6,890 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 59 | $1,447 |
| Atorvastatin Calcium | 52 | $1,258 |
| Omeprazole | 42 | $833 |
| Estradiol | 17 | $819 |
| Baclofen | 32 | $674 |
| Duloxetine Hcl | 30 | $660 |
| Rosuvastatin Calcium | 39 | $591 |
| Losartan Potassium | 36 | $587 |
| Potassium Chloride | 40 | $566 |
| Metoprolol Succinate | 25 | $478 |
| Tamsulosin Hcl | 29 | $433 |
| Montelukast Sodium | 21 | $403 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $117 | $46,76142 claims |
| PfizerEliquis | $72 | $21,07523 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Murfreesboro
- Scott EllerMurfreesboro$17K
- Rickey ManningKnoxville$8.1M
- Kymberly MoyerGallatin$5.9M
- Natasha BallardChattanooga$5.7M
- Hina BudhwaniNashville$4.7M
- Paul WakefieldKnoxville$4.3M
- Emily HubbsKingsport$2.8M
- Jerry PunchKnoxville$2.1M
- Bridgette FraneyNashville$2M
- Andrew BrockmyreBristol$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.